Microbix Biosystems Inc. (T:MBX)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Apr 11, 2024 07:00 am ET

Microbix Presenting at the 2024 Bloom Burton Conference

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking...

Apr 01, 2024 07:00 am ET

Microbix Announces Annual and Special Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held...

Mar 14, 2024 07:00 am ET

Microbix’s Clot-Buster Drug Project Advances

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed, with support from Microbix,...

Mar 11, 2024 07:00 am ET

Microbix Unveils Test Controls for Head and Neck Cancer

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of Quality Assessment Products (“QAPs™”) for supporting the quality control (“QC”) of...

Feb 26, 2024 07:00 am ET

Microbix Announces Issuance of Stock Options

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of...

Feb 14, 2024 07:13 am ET

Microbix Reports Record Results for Q1 Fiscal 2024

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2024 ended December 31, 2023 (“Q1”), with record quarterly revenues and a record...

Feb 07, 2024 07:00 am ET

Microbix Schedules Release of Results for Q1 Fiscal 2024

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal...

Feb 06, 2024 07:00 am ET

Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a Quality Assessment Product (“QAP™”) for supporting the clinical use and accuracy of...

Jan 03, 2024 07:00 am ET

Microbix Achieves Further QAPs Sales Record

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it has sold and shipped over one million Canadian Dollars (“C$ 1 Million”) of its quality assessment products (“QAPs™”)...

Dec 21, 2023 08:03 am ET

Microbix Reports Results for Q4 & Full-Year Fiscal 2023

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2023 (“2023” & “Q4”), with solid sales and a resumption of...

Dec 14, 2023 07:00 am ET

Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Seegene USA, Inc. (“Seegene USA”), a leading developer of multiplex molecular assays and automated...

Dec 07, 2023 07:00 am ET

Microbix & BioGX Collaborate on real-time PCR Assays & Controls

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with BioGX, Inc. (“BioGX”), a global provider of easy molecular diagnostic solutions. The companies are...

Dec 06, 2023 07:00 am ET

Microbix Announces Initiation of Normal Course Issuer Bid

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“NCIB”) program for the repurchase and cancellation of outstanding common...

Nov 17, 2023 07:00 am ET

Microbix Presenting at Florida Capital Event Conference

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Florida Capital Event Conference, organized by Capital Event Management...

Nov 16, 2023 07:00 am ET

Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the reconfirmation of its agreement (“Agreement”) with Sequel Pharma, LLC (“Sequel”) to return Kinlytic® urokinase...

Nov 10, 2023 07:00 am ET

Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces a collaboration with Ulisse Biomed S.p.A. (BIT: UBM, Ulisse), a company developing innovative diagnostics, theranostics,...

Oct 27, 2023 07:00 am ET

Microbix QAPs Supporting HPV Testing in Ireland

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its quality assessment products (“QAPs™”) are supporting a testing program for Human Papilloma Virus (“HPV”) using...

Sep 29, 2023 07:00 am ET

Microbix Presenting at Muskoka Capital Conference

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and...

Sep 27, 2023 07:00 am ET

Microbix Achieves New QAPs Sales Record

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has secured record purchase orders (“P.Os.”) for over one million Canadian Dollars (“C$ 1 Million”) of its...

Sep 13, 2023 04:01 pm ET

Microbix Honours the Passing of its Founder

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, honours the passing of its founder, William J. (Bill) Gastle, surrounded by family in Edmonton, Alberta on September 6, 2023. Bill...

Sep 05, 2023 09:00 am ET

Keynote Speakers and 34 Companies to Present at the Planet MicroCap Showcase: VANCOUVER on September 6-7, 2023 at the Fairmont Waterfront Vancouver

VANCOUVER, BC / ACCESSWIRE / September 5, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 6-7, 2023, where 29 MicroCap public companies will be presenting at the Fairmont Waterfront Vancouver, and 5 MicroCap public companies will be presenting virtually.

Aug 10, 2023 07:57 am ET

Microbix Reports Results for Q3 Fiscal 2023

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and YTD fiscal 2023 ended June 30, 2023 (“Q3” and “YTD”), a period in which strong revenues...

Aug 04, 2023 07:00 am ET

Microbix Successfully Upgrades Logistics Software Systems Achieves “Go-Live” with New ERP and eQMS Solutions

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its successful adoption of software to upgrade, digitize, and integrate its Enterprise Resource Planning (“ERP”) platform...

Jul 24, 2023 07:00 am ET

Microbix Presents Results of STI Test Controls at AACC

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of its Quality Assessment Products (“QAPs™”) for supporting the clinical use and accuracy...

Jul 05, 2023 07:00 am ET

Microbix QAPs Supporting HPV Testing Across The Netherlands

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its quality assessment products (“QAPs™”) have been selected to support a screening program for Human Papilloma...

Jun 20, 2023 07:00 am ET

Microbix & Labquality Create Novel Testing Accreditation Program

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter and Labquality Oy (Labquality), a global provider of laboratory external quality assessment (“EQA”) programs, announce their...

May 18, 2023 05:00 pm ET

Microbix Announces Extension of Warrant Expiry Date

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it has applied to the TSX to extend the term of an aggregate of 5,750,000 common share purchase warrants (“Warrants”)...

May 16, 2023 07:00 am ET

Microbix Secures Funded Drug Commercialization Agreement

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces execution of an agreement (“Agreement”) to return Kinlytic® urokinase (“Kinlytic”) to market, initially for dissolving...

May 11, 2023 07:30 am ET

Microbix Reports Results for Q2 Fiscal 2023

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2023 ended March 31, 2023 (“Q2” and “H1”), a period in which a loss...

Apr 20, 2023 07:00 am ET

Microbix Presenting at the 2023 Bloom Burton Conference

Mar 30, 2023 07:00 am ET

Microbix Announces Annual and Special Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”)...

Mar 20, 2023 07:00 am ET

Governments of Ontario and Canada Invest in Microbix

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products...

Mar 01, 2023 07:00 am ET

Microbix Supporting Australian Point-of-Care Testing Program

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its Quality Assessment Products (“QAPs™”) are now supporting test accuracy within a program to provide Point-of-Care...

Feb 27, 2023 07:00 am ET

Microbix Announces Issuance of Stock Options

Feb 09, 2023 07:29 am ET

Microbix Reports Results for Q1 Fiscal 2023 Sales of $2.5 million, Net Loss of $1.3 million

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter ended December 31, 2022 (“Q1”), a period in which reduced sales across two major product...

Feb 06, 2023 07:00 am ET

Microbix Presenting Results of Collaboration with Health PEI

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting results of its collaboration with the Microbiology Laboratory of the Queen Elizabeth Hospital...

Jan 30, 2023 07:00 am ET

Microbix Launches QAP to Support “Monkeypox” Testing

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is launching a new quality assessment product (“QAP™”) to support molecular diagnostic (“MDx”) testing for the...

Dec 22, 2022 07:30 am ET

Microbix Reports Record Sales for Fiscal 2022

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2022 (“2022” and “Q4”), with record sales and continued...

Oct 06, 2022 07:00 am ET

Microbix Presenting Test-Workflow Validation Results at EMMD

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian Cytology Service of the...

Sep 28, 2022 07:00 am ET

Microbix Announces Initiation of Normal Course Issuer Bid

Sep 21, 2022 07:00 am ET

Microbix Presenting at Muskoka Capital Conference

Aug 11, 2022 07:00 am ET

Microbix Reports Results for Q3 Fiscal 2022

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and year-to-date fiscal 2022 ended June 30, 2022 (“Q3” and “YTD”), with strong sales and...

Aug 10, 2022 07:00 am ET

Microbix Executes Substantial QAPs Supply Agreement

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the execution of a purchase and supply agreement (“Agreement”) by which Microbix “QAPs™” quality assessment products will...

Jul 26, 2022 07:00 am ET

Microbix Presenting STI Multiplex Test Controls at AACC

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it is presenting about the utility of its multi-pathogen (“multiplex”) and swab-formatted Quality Assessment Products...

Jun 03, 2022 07:00 am ET

Microbix Presenting Test Validation Methods at AACC

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it is presenting about the utility of its Quality Assessment Products (“QAPs™”) to monitor the end-to-end diagnostic...

May 12, 2022 07:30 am ET

Microbix Reports Record Results for Q2 Fiscal 2022

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2022 ended March 31, 2022 (“Q2” and “H2”), with record sales and...

Apr 29, 2022 07:00 am ET

Microbix Presenting Omicron Test Control Results at CVS

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will present performance results of its Quality Assessment Products (“QAPs™”) supporting molecular-diagnostic tests...

Apr 28, 2022 07:00 am ET

Microbix Presenting at the 2022 Bloom Burton Conference

Apr 19, 2022 07:00 am ET

Microbix Presenting Respiratory Virus Controls Data at Two Events

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be presenting performance results of its quality assessment products (“QAPs™”) that support molecular-diagnostic...

Apr 08, 2022 07:00 am ET

Microbix Presenting HPV Product Results at EUROGIN

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces it will present performance results of its Quality Assessment Products (“QAPs™”) supporting Human Papillomavirus (“HPV”)...

Mar 31, 2022 07:00 am ET

Microbix Announces Annual and Special Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the voting results from its Annual and Special Meeting of Shareholders (the “Meeting”) which was held on March 30, 2022. At the...

Mar 29, 2022 07:00 am ET

Microbix Invests to Further Scale Its Business

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces investment in programs to upgrade, digitize and fully-integrate its Quality Management System (“QMS”) and its Enterprise Resource...

Feb 24, 2022 07:00 am ET

Microbix Announces Issuance of Stock Options

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its...

Feb 22, 2022 07:00 am ET

Microbix Announces Nomination to Board of Directors

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Ms. Jennifer Stewart, an accomplished leader in Canadian business, government, and public affairs, has been nominated to become a...

Feb 17, 2022 07:00 am ET

Microbix Presenting at Capital Conference in B.C.

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it will be presenting to equity investors at the Whistler Capital Conference, organized by Capital Event Management Ltd. and being...

Feb 15, 2022 07:00 am ET

Microbix Advances Commissioning of Sites Two and Three

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces progress with expanding manufacturing capacity of its portfolio of Quality Assessment Products (“QAPs™”) and its “DxTM™” brand viral...

Feb 10, 2022 07:00 am ET

Microbix Reports Record Results for Q1 Fiscal 2022

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its first quarter ended December 31, 2021 (“Q1”), with record sales and earnings, plus ongoing progress upon its strategic...

Feb 01, 2022 07:00 am ET

Microbix Launches Omicron Variant Test Control

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio of Quality Assessment Products (“QAPs™”) to include a swab-formatted control that helps validate the...

Dec 24, 2021 07:00 am ET

Microbix Receives $4.7 Million Order for Viral Transport Medium

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces receipt of a follow-on order of C$ 4.7 million for its viral transport medium (generically known as “VTM” and branded “DxTM™” by...

Dec 23, 2021 07:11 am ET

Microbix Reports Record Results for Fiscal 2021

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its year and fourth quarter ended September 30, 2021 (“2021” and “Q4”), with record sales and earnings, plus progress upon its...

Dec 20, 2021 07:00 am ET

Microbix Launches Multiplex Respiratory PCR-Test Control

Nov 17, 2021 07:00 am ET

Microbix Expands Pandemic Test Controls (QAPs™) Portfolio

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio of Quality Assessment Products (“QAPs™”) to include controls that support PCR tests for each of the four...

Oct 27, 2021 07:00 am ET

Microbix Receives $2.7 Million from Exercise of Warrants

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has received C$ 2.7 million from the partial exercise of two series of expiring share purchase warrants. The first series of...

Oct 04, 2021 07:00 am ET

Microbix Makes Early Repayment of 9% Interest Debenture

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has completed the early repayment of a debenture series on which it owed C$ 1.3 million and was paying an interest rate of 9.0%....

Sep 27, 2021 07:00 am ET

Microbix Presenting Product Results at AACC

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has been invited to present about the performance of its COVID-19 test quality assessment products (QAPs™) at “AACC” the annual...

Sep 23, 2021 07:00 am ET

Microbix Presenting at Muskoka Capital Conference

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted...

Aug 12, 2021 07:30 am ET

Microbix Reports Record Results for Q3 Fiscal 2021

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its third quarter and nine months of fiscal 2021 ending June 30, 2021 (“Q3” and “YTD”), with record sales and earnings, plus...

Aug 03, 2021 07:00 am ET

Microbix Upgrades U.S. OTC Market & Investor Relations

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has undertaken two actions to improve its profile with United States (U.S.) based investors and to improve its trading liquidity...

Jul 08, 2021 07:00 am ET

Microbix Presenting Product Results to Industry

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has been invited to present about the performance of its COVID-19 test quality assessment products (QAPs™) at “ECCMID 2021” the...

Jul 07, 2021 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the appointment of Thomas Scientific LLC as distributor of Microbix’s quality assessment products (QAPs™) for the United States....

Jun 03, 2021 07:00 am ET

Microbix Secures Third Ontario Manufacturing Site

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has secured a third manufacturing site in Mississauga, Ontario, by way of a long-term lease agreement for a property adjacent to...

May 31, 2021 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the appointment of SDT Molecular Pte Ltd (SDT) as distributor of Microbix’s quality assessment products (QAPs™) for four Asia-Pacific...

May 19, 2021 09:09 am ET

Microbix Announces Closing of Offering and Private Placement

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces it has closed its previously-announced bought-deal public offering (the “Offering”) and concurrent private placement (the “Placement”)....

May 13, 2021 06:29 pm ET

Microbix Reports Record Results for Q2 Fiscal 2021

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its second quarter and first half of fiscal 2021 ending March 31, 2021 (“Q2” and “H1”), with record sales and earnings, plus...

Apr 29, 2021 08:10 am ET

IIROC Trade Resumption - MBX

TORONTO, April 29, 2021 /CNW/ - Trading resumes in:

Apr 28, 2021 04:06 pm ET

Microbix Announces $6.0 Million of Financings

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce it has entered into an agreement with iA Private Wealth Inc. and Bloom Burton Securities Inc. (the "Underwriters"), who...

Apr 28, 2021 03:52 pm ET

IIROC Trading Halt - MBX

TORONTO, April 28, 2021 /CNW/ - The following issues have been halted by IIROC:

Apr 26, 2021 07:00 am ET

Microbix & SpeeDx Form Exclusive Collaboration

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and SpeeDx Pty. Ltd. (SpeedDx), a developer of innovative molecular diagnostics solutions, are pleased to announce the formation of a...

Apr 23, 2021 11:12 am ET

IIROC Trade Resumption - MBX

TORONTO, April 23, 2021 /CNW/ - Trading resumes in:

Apr 23, 2021 10:59 am ET

Microbix Receives $4.25 Million Order For Viral Transport Medium

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has received an initial order of CDN$ 4.25 million for its viral transport medium (generically known as “VTM” and branded as...

Apr 23, 2021 10:32 am ET

IIROC Trading Halt - MBX

TORONTO, April 23, 2021 /CNW/ - The following issues have been halted by IIROC:

Apr 19, 2021 07:00 am ET

Microbix to Present at Bloom Burton Investor Conference

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that its CEO, Cameron Groome, has been invited to present at the 2021 Bloom Burton & Co. Healthcare Investor Conference, being held...

Mar 31, 2021 07:00 am ET

Microbix Announces Annual and Special Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held...

Mar 15, 2021 07:00 am ET

Microbix & Seegene Canada Form COVID-Variant Collaboration

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Seegene Canada Inc. (Seegene®), a provider of leading-edge molecular diagnostics assays and instruments (made by Seegene Inc. of Seoul,...

Mar 11, 2021 07:00 am ET

Microbix Antigen-test QAPs Now Available For Clinical Use

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability of more of its Quality Assessment Products (QAPs™) as In-Vitro Diagnostic “IVD” Controls – to monitor the workflow...

Feb 18, 2021 07:00 am ET

Microbix Announces Issuance of Stock Options Using Shareholder-Approved Plan to Incentivize and Retain

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its...

Feb 16, 2021 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces an agreement (Agreement) with Oneworld Accuracy Inc. (1WA) to distribute Microbix’s Quality Assessment Products (QAPs™) on a...

Feb 11, 2021 08:22 am ET

Microbix Reports Results for Q1 Fiscal 2021

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for the first quarter of its fiscal 2021, the three-months ended December 31, 2020 (“Q1”), with record sales and continued...

Feb 09, 2021 07:00 am ET

Microbix Announces Material First Sales of Viral Transport Medium

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce material first sales of its viral transport medium (generically known as VTM and branded as DxTM™) that supports Canadian...

Jan 28, 2021 07:00 am ET

Microbix Viral Transport Medium Now Available

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce the commercial availability of its viral transport medium (VTM) to support Canadian RT-PCR (molecular) testing for the...

Dec 21, 2020 07:00 am ET

Microbix & Copan Italia Execute Strategic Agreement

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan®), the global leader in specimen collection technologies, announce their execution of a strategic agreement...

Dec 18, 2020 07:38 am ET

Microbix Reports Results for Fiscal 2020

Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, reports results for its 2020...

Dec 15, 2020 07:00 am ET

Microbix Presenting Product Results at AACC

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces it has been invited to present about the performance of two types of its test-workflow Quality Assessment Products (QAPs™) at the 2020...

Dec 07, 2020 07:00 am ET

Microbix Announces Addition to Board of Directors

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Mr. Anthony J. Giovinazzo, an accomplished leader in the international life sciences industry, has joined its Board of Directors....

Oct 29, 2020 07:00 am ET

Microbix Discloses New Products, Sales and Capacity

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability and initial material sales of “onboarding” kits of its quality assessment products (QAPs™), designed to help testing...

Oct 20, 2020 07:00 am ET

Microbix Creates Further COVID-19 Quality Assessment Products

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces its creation, external verification, initial sales, and first shipments of a new class of quality assessment products (QAPs™) to help...

Oct 15, 2020 07:00 am ET

Microbix Launches New STI-Related Quality Assessment Products

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces its creation, external verification, and registration of new quality assessment products (QAPs™) to help ensure the accuracy of...

Oct 13, 2020 07:00 am ET

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, is pleased to announce the execution of a grant agreement with the Ontario Together Fund (OTF) of the Ministry of Economic Development, Job...

Sep 22, 2020 07:00 am ET

Microbix Presenting COVID-19 Product Results to Industry

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it is has been invited to present about the performance of its COVID-19 in-vitro diagnostics (IVD) quality assessment...

Sep 17, 2020 07:00 am ET

Microbix Announces Extension of Warrant Expiry Dates

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it has applied to the TSX to extend the term of an aggregate of 7,413,052 common share purchase warrants (“Warrants”)...

Sep 15, 2020 07:00 am ET

Microbix Announces Board Changes

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces that its founder and Executive Chairman William J. (Bill) Gastle has elected to retire effective October 15, 2020, and...

Sep 10, 2020 07:00 am ET

Microbix’s REDx™ Controls Attain Australian TGA Registration

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce attainment of Australian Therapeutic Goods Administration (TGA) registration for its COVID-19 and high-risk...

Aug 14, 2020 07:00 am ET

Microbix Reports Results for Q3 Fiscal 2020

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, reports results for its third quarter and year to date fiscal 2020 (Q3 and YTD) ended June 30, 2020, with an increase of 141% in sales of...

Jul 14, 2020 07:00 am ET

Microbix Shares Become Available for U.S. Investors

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces that it has completed two processes to make its common shares available for U.S. investors to buy and sell; (i) the...

Jun 05, 2020 07:00 am ET

Microbix COVID-19 QAPs Attain EU “CE mark” Registration

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce the attainment of European Union “CE mark” (Conformité Européene) registration for its SARS-CoV-2 quality assessment...

Jun 04, 2020 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Alpha-Tec Systems, Inc. (Alpha-Tec), a Calibre Scientific Inc. firm, as distributor of its Quality Assessment...

Jun 01, 2020 09:55 am ET

Microbix Engaged to Develop & Supply Custom QAPs

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has been engaged to develop and supply custom quality assessment products (QAPs™) to support the registration and sales of a...

May 27, 2020 07:00 am ET

Microbix Expanding QAPs™ Production Capacity

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has begun a build-out of its second facility that is initially intended to support a tenfold increase of production capacity...

May 19, 2020 07:00 am ET

Microbix Achieves Full Utilization of its Bioreactors

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has achieved full utilization of the six bioreactor units it installed for manufacturing the “antigens” which are at the core...

May 15, 2020 07:38 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of R-Biopharm AG (R-Biopharm) as distributor of its Quality Assessment Products (QAPs™) in eleven (11) countries....

May 14, 2020 07:00 am ET

Microbix Reports Results for Q2 Fiscal 2020

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, reports results for its second quarter and first half of fiscal 2020 (“Q2” and “H1”) ended March 31, 2020, with the timing of product shipments...

May 12, 2020 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Diagnostic International Distribution S.p.A. of Milan (D.I.D.) as distributor of its Quality Assessment Products...

May 07, 2020 07:00 am ET

Microbix COVID-19 QAPs Now Available for U.S. Labs

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, is pleased to announce U.S. availability of its SARS-CoV-2 quality assessment products (QAPs™) – FDA registration enabling immediate usage by...

May 06, 2020 07:00 am ET

Microbix Begins Providing COVID-19 Test Quality Products

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has begun providing its REDx™FLOQ® SARS-CoV-2 swab-format and REDx™ SARS-CoV-2 vial format quality assessment products (QAPs™)...

Apr 27, 2020 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Labquality Oy (Labquality) as a distributor of its Quality Assessment Products (QAPs™) in seven (7) countries....

Apr 21, 2020 12:00 pm ET

IIROC Trade Resumption - MBX

TORONTO, April 21, 2020 /CNW/ - Trading resumes in:

Apr 21, 2020 11:49 am ET

Microbix Attains Health Canada Establishment Licensing

Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator and exporter, announces that it has attained medical devices establishment licensing from Health Canada, enabling the immediate usage of its quality assessment products...

Apr 21, 2020 10:35 am ET

IIROC Trading Halt - MBX

TORONTO, April 21, 2020 /CNW/ - The following issues have been halted by IIROC:

Apr 21, 2020 07:00 am ET

Microbix Participating in COVID-19 Virtual Conference

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it will be participating in the “Virtual COVID & Healthcare Mini Conference” being hosted by Adelaide Capital on April 23 from...

Apr 09, 2020 07:00 am ET

Microbix & Oneworld Create COVID-19 Test Quality Program

Microbix Biosystems Inc. (TSX: MBX, Microbix®) and Oneworld Accuracy (1WA) announce a strategic collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing. Based in Canada, this...

Apr 01, 2020 05:36 pm ET

Microbix Announces Annual and Special Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX, “Microbix®” or the “Company”), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces the...

Mar 30, 2020 07:00 am ET

Microbix Creates Quality Assessment Product for COVID-19 Tests

Microbix Biosystems Inc. (TSX: MBX, Microbix®) announces the creation, verification, and imminent commercial availability of a quality assessment product (QAP™) to help ensure the accuracy of COVID-19 disease testing. By creating this unique...

Mar 25, 2020 07:00 am ET

Microbix Annual General Meeting Process Update

Mar 24, 2020 07:00 am ET

Microbix Announces Quality Products Distribution Agreement

Feb 25, 2020 07:00 am ET

Microbix Announces Issuance of Stock Options

Feb 13, 2020 07:00 am ET

Microbix Reports Results for Q1 Fiscal 2020

Jan 31, 2020 07:00 am ET

Microbix Completes Non-Brokered Private Placement of $2.3 million

Dec 20, 2019 08:21 am ET

Microbix Reports Results for Fiscal 2019

Dec 02, 2019 07:00 am ET

Microbix Invited to Present Product Results at HPV Congress

Nov 18, 2019 07:00 am ET

Microbix Wins Ontario Business Award

Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices (QAPs™) that help ensure test accuracy, announces it has been...

Oct 08, 2019 07:00 am ET

Microbix Presenting Product Results at Industry Conference

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and quality control medical devices, announces it is making two presentations about the performance of its in-vitro diagnostics quality products (IVD...

Oct 01, 2019 07:00 am ET

Microbix Presenting at StableView TECH19 Conference

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and quality control medical devices, announces that it will be presenting to investors about Microbix at the StableView TECH19 conference, organized by...

Sep 25, 2019 07:00 am ET

Microbix Presenting at Muskoka Capital Conference

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of clinical diagnostic materials and medical devices for test quality control, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference,...

Sep 19, 2019 07:00 am ET

Microbix Quality Products Enter U.S. Market

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce U.S. availability of four innovative in-vitro diagnostic (IVD) control products for evaluating performance, procedures, and...

Sep 05, 2019 07:00 am ET

Microbix Quality Products Attain European Registration

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce European registration for four innovative in-vitro diagnostic (IVD) control products for evaluating performance,...

Aug 12, 2019 07:00 am ET

Microbix Reports Results for Q3 Fiscal 2019

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its third quarter and nine months of fiscal 2019, the three-month and nine-month periods ending June 30, 2019 (“Q3” & “YTD”),...

Aug 01, 2019 07:00 am ET

Microbix Provides Bioreactor Update

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on the conversion of its highest-selling product into bioreactors – that the largest customer for that antigen has confirmed...

Jul 30, 2019 07:00 am ET

FedDev Ontario Supports New Microbix Facility in Mississauga

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, is pleased to announce the execution of a contribution agreement with the Federal Economic Development Agency for Southern Ontario (FedDev...

May 13, 2019 07:00 am ET

Microbix Reports Results for Q2 Fiscal 2019

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its second quarter and first half of fiscal 2019, the three-month and six-month periods ending March 31, 2019 (“Q2” & “H1”),...

Apr 29, 2019 07:00 am ET

Microbix to Present at Bloom Burton Conference

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that its CEO, Cameron Groome, has been invited to present at the 2019 Bloom Burton & Co. Healthcare Investment Conference, being held at...

Apr 18, 2019 07:00 am ET

Microbix Announces Management Changes

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has appointed Dr. Kenneth (Ken) Hughes as its Chief Operating Officer (“COO”) and that Mrs. Kathryn Froh, its Vice President,...

Mar 28, 2019 04:21 pm ET

Microbix Announces Annual Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX, “Microbix” or the “Company”), an innovator of biological products and technologies, announces the voting results from the Annual Meeting of Shareholders (the “Meeting”) which was held on March 27, 2019. At the...

Feb 25, 2019 07:00 am ET

Microbix Announces Issuance of Stock Options

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces the issuance of stock options under its shareholder-approved 2018 stock option plan (the “Stock Option Plan”), as part of its...

Feb 12, 2019 07:00 am ET

Microbix Reports Results for Q1 Fiscal 2019

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its first quarter of fiscal 2019, the three-month period ending December 31, 2018 (“Q1”), with lower sales, improving...

Feb 05, 2019 07:00 am ET

Microbix Provides Quality Assessment Products Update

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on the expansion of its quality assessment product lines, announcing the addition of new customers, more products, and steps to...

Dec 24, 2018 07:00 am ET

Microbix Enhances Quality Management System

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has attained the ISO 13485:2016 Medical Devices certification – an enhancement to its quality management system that is expected...

Dec 21, 2018 08:30 am ET

Microbix Reports Results for Fiscal 2018

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for its fourth quarter of fiscal 2018, the three-month period ending September 30, 2018 (“Q4”), with strong sales and progress...

Nov 19, 2018 07:00 am ET

Microbix Wins Business Award of Excellence

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has been recognized with the 2018 Business Innovation Award by the Mississauga Board of Trade (MBOT). The award was provided to...

Nov 06, 2018 07:00 am ET

Microbix Exhibiting at MEDICA Trade Fair

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be exhibiting its antigens and quality assessment products at MEDICA, a leading international trade fair for the medical...

Sep 27, 2018 07:00 am ET

Microbix to Present at Muskoka Capital Conference

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it will be presenting to investors about Microbix at the Muskoka Capital Conference, organized by Capital Event Conferences and...

Aug 14, 2018 07:00 am ET

Microbix Reports Record Third Quarter Sales

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial results for its third quarter of fiscal 2018, the three-month period ending June 30, 2018 (“Q3”), with record sales and progress...

Jul 26, 2018 07:00 am ET

Microbix Exhibiting at AACC Exposition

Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces that it will be exhibiting its Quality Assessment Products (QAPs™) at the 70th annual clinical laboratory exposition of the American...

Jul 12, 2018 07:00 am ET

Microbix to Present at Okanagan Capital Conference

Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces that it will be presenting to investors about Microbix at the Okanagan Capital Conference, organized by Capital Event Conferences and...

May 14, 2018 07:00 am ET

Microbix Reports Record Second Quarter Sales

Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, reports financial results for its second quarter of fiscal 2018, the three-month period ending March 31, 2018 (“Q2”), with record sales and...

May 08, 2018 07:00 am ET

Microbix Completes Multiple Facility Upgrades

Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces the completion of multiple upgrades to its production facility, to improve its revenue capacity and in support of corporate growth...

Apr 30, 2018 07:00 am ET

Microbix to Present at Bloom Burton Conference

Healthcare Investment Conference in Toronto on May 2 & 3, 2018

Apr 26, 2018 07:00 am ET

Microbix Engages Drug Licensing Advisor

Torreya Partners to Assist with Kinlytic® urokinase

Apr 02, 2018 05:00 pm ET

Microbix Announces Annual and Special Meeting Voting Results

TORONTO, April 02, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces the voting results from the Annual and Special Meeting of Shareholders (the “Meeting”) that was held on March...

Mar 19, 2018 02:30 pm ET

Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors

MONCTON, New Brunswick, March 19, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce that Marc Rubin, MD and Vaughn Embro-Pantalony have been appointed to...

Feb 14, 2018 07:00 am ET

Microbix Reports Record First Quarter Sales

Year-Over-Year Sales Growth of 48%

Jan 29, 2018 07:00 am ET

Microbix Featured at Cantech Investment Conference

Invited onto Panel about Managing Canadian Healthcare Companies for Growth

Jan 18, 2018 07:00 am ET

Microbix Expands Quality Assessment Product Family

Microbix Biosystems Inc. (TSX: MBX) (Microbix(R)), an innovator of biological products and technologies, announces the expansion of its quality assessment product family, with 48 new products being completed and made available for sale under its PTDx(TM) and PROCEEDx(TM) brands.

Jan 18, 2018 06:58 am ET

Microbix Expands Quality Assessment Product Family

Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, announces the expansion of its quality assessment product family, with 48 new products being completed and made available for sale under its...

Dec 21, 2017 07:00 am ET

Microbix Reports Full Year and Fourth Quarter Results

Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, reports financial results for its fiscal year and fourth quarter ended 30 September, 2017 ("2017" and "Q4").

Dec 21, 2017 06:58 am ET

Microbix Reports Full Year and Fourth Quarter Results

Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, reports financial results for its fiscal year and fourth quarter ended 30 September, 2017 ("2017" and "Q4"). Management Discussion In 2017,...

Nov 27, 2017 07:00 am ET

Microbix Confirms Ramp-up of Production

Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, confirms its production ramp-up, with a 500% increase in bioreactor capacity and other processing upgrades.

Nov 27, 2017 06:58 am ET

Microbix Confirms Ramp-up of Production

Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, confirms its production ramp-up, with a 500% increase in bioreactor capacity and other processing upgrades. Microbix' revenues are mainly...

Oct 27, 2017 07:00 am ET

Microbix Completes Second Tranche of Brokered Private Placement

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a second and final tranche of the brokered private placement financing announced on October 19, 2017. An aggregate of 7,784,500 Units were issued in the first tranche for gross proceeds of $2.33 million. Microbix has now closed a second tranche of private placement financing for further gross proceeds of $1.17 million, resulting in the issue of 3,882,133 more Units at a price of $0.30 per Unit.

Oct 27, 2017 06:58 am ET

Microbix Completes Second Tranche of Brokered Private Placement

Oct 19, 2017 07:00 am ET

Microbix Completes Brokered Private Placement

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in the issue of 7,784,500 million units ("Units") at a price of $0.30 per unit.

Oct 19, 2017 06:58 am ET

Microbix Completes Brokered Private Placement

Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), a developer and marketer of biological products and technologies, announces that it has completed a brokered private placement financing totaling $2.33 million dollars, resulting in...

Oct 11, 2017 07:00 am ET

Microbix Announces End of Legal Dispute

Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, is pleased to announce the withdrawal of legal claims alleging patent infringement that were filed in Canadian Federal Court against Microbix by ZeptoMetrix Corporation in October, 2016.

Sep 13, 2017 08:30 am ET

Microbix Announces First Shipment of Bioreactor Antigen

Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation.

Sep 13, 2017 08:28 am ET

Microbix Announces First Shipment of Bioreactor Antigen

Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation....

Aug 24, 2017 08:30 am ET

Microbix to Amend Share Purchase Warrant Terms

Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the "Warrants") issued in connection with a non-brokered private placement and held by one of its independent directors.

Aug 24, 2017 08:28 am ET

Microbix to Amend Share Purchase Warrant Terms

Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, announces it has applied to the TSX to amend the terms of 1,500,000 common share purchase warrants (the "Warrants") issued in connection with...

Aug 14, 2017 07:00 am ET

Microbix Reports Record Third Quarter & Nine Month Sales

Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reports financial results for its fiscal third quarter and nine months ended June 30, 2017 ("Q3" and "9 Mo.").

Aug 14, 2017 06:58 am ET

Microbix Reports Record Third Quarter & Nine Month Sales

Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, today reports financial results for its fiscal third quarter and nine months ended June 30, 2017 ("Q3" and "9 Mo."). Third Quarter Financial Results...

Aug 08, 2017 08:00 am ET

Microbix Announces Expanded Customer Supply Agreement

Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix' viral antigen products over the next five years, with the parties having the option to extend that term. Sales from the agreement are expected to total $25 million, with approximately $10 million being new business.

Aug 08, 2017 07:58 am ET

Microbix Announces Expanded Customer Supply Agreement

Jul 24, 2017 08:59 am ET

Microbix Announces Leadership Transition

Jul 24, 2017 08:59 am ET

Microbix Announces Leadership Transition

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has appointed Mr. Cameron Groome as its President and CEO, with Mr. Vaughn Embro-Pantalony retiring from those positions but remaining an executive director working closely with Mr. Groome to ensure a smooth leadership transition.

May 15, 2017 08:30 am ET

Microbix Reports Strong First Half Sales Growth

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal second quarter and six months ended March 31, 2017 ("Q2" and "H1").

May 15, 2017 08:28 am ET

Microbix Reports Strong First Half Sales Growth

Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal second quarter and six months ended March 31, 2017 ("Q2" and "H1")....

May 01, 2017 08:00 am ET

Microbix Consults with FDA Regarding Plans for Kinlytic(R) Urokinase

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has consulted with the U.S. Food and Drug Administration (the "FDA") regarding the Company's plans to return its thrombolytic biologic drug, Kinlytic(R) Urokinase ("Kinlytic"), to the U.S. market.

May 01, 2017 07:58 am ET

Microbix Consults with FDA Regarding Plans for Kinlytic(R) Urokinase

Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company") a developer and marketer of biological products and technologies, announces that it has consulted with the U.S. Food and Drug Administration (the "FDA") regarding the Company's plans...

Apr 28, 2017 07:58 am ET

Microbix Announces Amendments to Debenture and Share Purchase Warrants

Not for distribution in the United States or through United States wire services. Microbix Biosystems Inc. (TSX:MBX), an innovator of biological products and technologies, announced today it has negotiated an extension...

Mar 30, 2017 08:51 am ET

Microbix Announces Annual Meeting Voting Results

Mar 30, 2017 08:51 am ET

Microbix Announces Annual Meeting Voting Results

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announces the results of the Annual Meeting of Shareholders which was held on March 29, 2017, at which 37.07% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. A detailed description of all resolutions that were voted on can be reviewed in the Company's Information Circular which was filed on SEDAR on February 22, 2017. All of the director nominees listed in the Information

Feb 14, 2017 09:44 am ET

Microbix Reports Significant Revenue Growth in First Quarter

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December 31, 2016.

Feb 14, 2017 09:44 am ET

Microbix Reports Significant Revenue Growth in First Quarter

Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December 31, 2016. First Quarter Financial Results...

Jan 12, 2017 08:00 am ET

Microbix Appoints Meridian Life Science as Distributor in Asia Pacific

Microbix Biosystems Inc. (TSX: MBX) ("Microbix"), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the "Agreement") with Meridian Life Science, Inc. ("Meridian") a wholly owned company of Meridian Bioscience, Inc. (NASDAQ: VIVO) a fully integrated global diagnostic and life science company.

Jan 12, 2017 07:58 am ET

Microbix Appoints Meridian Life Science as Distributor in Asia Pacific

Microbix Biosystems Inc. (TSX:MBX) ("Microbix"), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the "Agreement") with Meridian Life Science, Inc. ("Meridian") a wholly owned company of...

Dec 23, 2016 08:00 am ET

Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for the three months and year ended September 30, 2016, and provided an update on its operations.

Dec 23, 2016 07:58 am ET

Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth

Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today reported financial results for the three months and year ended September 30, 2016, and provided an update on its...

Dec 12, 2016 08:42 am ET

Microbix Arranges New Revolving Credit Facility

Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today announced that it has arranged a new secured revolving credit facility jointly with The Toronto-Dominion Bank ("TD Bank") and Export Development Canada ("EDC").

Dec 12, 2016 08:42 am ET

Microbix Arranges New Revolving Credit Facility

Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today announced that it has arranged a new secured revolving credit facility jointly with The Toronto-Dominion Bank ("TD Bank")...

Nov 01, 2016 08:30 am ET

Microbix Appoints New Chief Financial Officer

Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced that Charles Wallace, the Company's Chief Financial Officer, is retiring on December 31, 2016 after serving in this capacity since September 2013. Microbix also announced that Jim Currie is joining the Company on November 1, 2016 as the newly appointed Chief Financial Officer.

Nov 01, 2016 08:28 am ET

Microbix Appoints New Chief Financial Officer

Oct 19, 2016 08:30 am ET

Microbix Announces Preliminary Sales for 2016

Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced preliminary revenue results (unaudited) for its fourth quarter and full year ending September 30, 2016. The preliminary results are subject to the Company's annual audit including a review of its revenue recognition policies under IFRS. The Company's audited financial results will be available towards the end of December 2016.

Ad blocking detected

Microbix Biosystems Inc. (T:MBX)

Business Focus: Biotechnology & Medical Research (NEC)